Premium
Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
Author(s) -
Leesar Massoud A.
Publication year - 2016
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26850
Subject(s) - medicine , cardiology , coronary angiography , radiology , myocardial infarction
Key Points There are now data supporting the use of the Absorb everolimus‐eluting bioresorbable vascular scaffold (BVS) for treating non‐complex coronary lesions. The complete bioresorption of the scaffold after 2–3 years is an important advantage over metallic stents because there will not be a nidus for stent‐related thrombotic complications. The safety and efficacy of BVS has yet to be determined in patients with coronary bifurcation lesions